Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

All Drugs Associated with Second primary malignancy (Page 5)

237 drugs have been associated with Second primary malignancy in FAERS reports.

Drug Reports Deaths Hosp. Life-Threat.
GABAPENTIN 6 1 0 0
GEMTUZUMAB OZOGAMICIN 6 1 1 0
LENOGRASTIM 6 4 0 1
OMEPRAZOLE 6 3 2 0
PANOBINOSTAT 6 3 2 1
PIRFENIDONE 6 0 3 0
POTASSIUM 6 0 4 0
RANIMUSTINE 6 1 1 0
TROFOSFAMIDE 6 5 0 0
VINORELBINE\VINORELBINE 6 0 2 0
ACETAMINOPHEN 5 0 0 0
ACLARUBICIN 5 3 1 1
ALBUTEROL 5 1 2 0
AROMASIN 5 4 1 0
AVELUMAB 5 0 1 3
AZATHIOPRINE 5 3 3 3
BICALUTAMIDE 5 1 3 0
CILTACABTAGENE AUTOLEUCEL 5 3 1 1
CISPLATIN\PACLITAXEL 5 0 0 0
CLADRIBINE 5 2 1 1
CLINDAMYCIN 5 0 5 0
DARBEPOETIN ALFA 5 1 1 0
DECITABINE 5 4 2 1
DEXRAZOXANE 5 1 3 0
DUTASTERIDE 5 0 0 0
ELOTUZUMAB 5 2 2 0
FLUCONAZOLE 5 1 3 0
LUTETIUM LU-177 5 0 4 0
LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN 5 4 1 1
MAGNESIUM 5 1 1 0
NELARABINE 5 0 3 1
NIMUSTINE 5 1 0 0
PENTOSTATIN 5 2 0 0
REGORAFENIB 5 0 2 0
TECLISTAMAB 5 2 2 3
TEMSIROLIMUS 5 1 1 0
TUCATINIB 5 0 0 0
« 1 2 3 4 5